USA Financial Formulas’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-44
Closed -$13K 437
2026
Q1
$13K Sell
44
-736
-94% -$219K ﹤0.01% 285
2025
Q4
$213K Sell
780
-187
-19% -$50.8K 0.04% 125
2025
Q3
$261K Sell
967
-131
-12% -$35.6K 0.05% 121
2025
Q2
$303K Buy
1,098
+232
+27% +$63.1K 0.05% 99
2025
Q1
$230K Buy
+866
New +$214K 0.04% 124
2024
Q1
Sell
-5,285
Closed -$1.11M 323
2023
Q4
$1.11M Buy
5,285
+5,269
+32,931% +$1.12M 0.19% 66
2023
Q3
$3.2K Hold
16
﹤0.01% 289
2023
Q2
$2.96K Hold
16
﹤0.01% 266
2023
Q1
$3.06K Buy
+16
New +$2.89K 0.01% 194
2018
Q4
Sell
-16,012
Closed -$2.63M 327
2018
Q3
$2.63M Sell
16,012
-6,189
-28% -$1.04M 0.66% 49
2018
Q2
$3.59M Sell
22,201
-154
-0.7% -$25.2K 0.87% 44
2018
Q1
$3.62M Buy
+22,355
New +$3.56M 0.87% 44
2017
Q2
Sell
-22,412
Closed -$2.66M 235
2017
Q1
$2.66M Buy
+22,412
New +$2.7M 0.64% 61
2015
Q2
Sell
-22,656
Closed -$2.15M 220
2015
Q1
$2.15M Buy
+22,656
New +$2.1M 0.7% 52

Other funds holding CME

USA Financial Formulas's CME Position: Q2 2026 in Review

USA Financial Formulas sold out of CME Group (CME) in Q2 2026, closing a stake of 44 shares — an estimated $13K sold.

USA Financial Formulas first reported a position in CME in Q1 2015 and held it in 14 quarters. The position peaked at $3.62M in Q1 2018. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • USA Financial Formulas reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 44 CME Group shares in Q2 2026, an estimated $13K.
  • USA Financial Formulas first reported a position in CME Group in Q1 2015 and held it in 14 quarters.
  • USA Financial Formulas's CME Group position peaked at $3.62M in Q1 2018.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.